Vericiguat:药理学概况

Q4 Health Professions Klinicka Farmakologie a Farmacie Pub Date : 2022-07-07 DOI:10.36290/far.2022.013

K. Urbánek

{"title":"Vericiguat:药理学概况","authors":"K. Urbánek","doi":"10.36290/far.2022.013","DOIUrl":null,"url":null,"abstract":"Approximately 53 % of the administered dose is excreted in the urine, while 45% in the faeces. The biological elimination half-life in healthy volunteers averaged 20 hours and in patients with heart failure averaged 30 hours. Its most common adverse effect with an incidence of about 16% is hypotension. It has minimal potential for drug interactions.","PeriodicalId":39116,"journal":{"name":"Klinicka Farmakologie a Farmacie","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vericiguat: pharmacological profile\",\"authors\":\"K. Urbánek\",\"doi\":\"10.36290/far.2022.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Approximately 53 % of the administered dose is excreted in the urine, while 45% in the faeces. The biological elimination half-life in healthy volunteers averaged 20 hours and in patients with heart failure averaged 30 hours. Its most common adverse effect with an incidence of about 16% is hypotension. It has minimal potential for drug interactions.\",\"PeriodicalId\":39116,\"journal\":{\"name\":\"Klinicka Farmakologie a Farmacie\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicka Farmakologie a Farmacie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36290/far.2022.013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka Farmakologie a Farmacie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36290/far.2022.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}

引用次数: 0

摘要

大约53%的给药剂量通过尿液排出，而45%通过粪便排出。健康志愿者的生物消除半衰期平均为20小时，心力衰竭患者的平均为30小时。其最常见的不良反应是低血压，发生率约为16%。它与药物相互作用的可能性很小。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Vericiguat: pharmacological profile

Approximately 53 % of the administered dose is excreted in the urine, while 45% in the faeces. The biological elimination half-life in healthy volunteers averaged 20 hours and in patients with heart failure averaged 30 hours. Its most common adverse effect with an incidence of about 16% is hypotension. It has minimal potential for drug interactions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Klinicka Farmakologie a Farmacie Health Professions-Pharmacy

CiteScore

0.30

自引率

0.00%

发文量